McKesson Corp (MCK)
$151.51
1.22 (0.80%)
MCK Stock Quote Delayed 30 Minutes
Previous Close
$151.51
Market Cap
30.57B
PE Ratio
505.03
EPS
0.3
Volume (Avg. Vol.)
706,388
Day's Range
150.38 - 154.83
52-Week Range
112.60 - 172.18
Dividend & Yield
1.41 (0.93%)
MCK Stock Predictions, Articles, and McKesson Corp News
4 Top Stock Trades for Thursday: LOW, TGT, MRNA, MCK
Target, Lowe's, McKesson and Moderna were our top stock trades for Thursday. That said, here's what the charts look like now.
McKesson Earnings: MCK Stock Up 1% On Q4 Beat
McKesson (MCK) earnings for the healthcare company's fiscal fourth quarter of 2020 have MCK stock up Wednesday after beating estimates.
3 Big Stock Charts for Thursday: Broadcom, Kimberly-Clark, and McKesson
U.S. stocks look a bit uncertain at the moment. These 3 stocks could be particularly susceptible to broader movements.
Stock Market Today: Stocks Rally Ahead of Big Earnings Week
Another opioid settlement has been reached and earnings season is heating up. Here's what happened in the stock market today.
3 Big Stock Charts for Wednesday: McKesson, O’Reilly Automotive and Seagate Technology
The stock charts of STX, ORLY and MCK are headed into the middle of the week on the verge of significant moves.
3 Big Stock Charts for Tuesday: McKesson, Dish Network and Gilead Sciences
The stock charts of GILD, DISH and MCK are put under the trading microscope as the next great trading prospects.
3 Big Stock Charts for Monday: CenterPoint Energy, McKesson and Coca-Cola
The stock charts of KO, MCK and CNP stock are going to get the new week started on a potentially explosive foot.
Walgreens Faces Kentucky Lawsuit for Dispensing Opioids at Alarming Rate
Walgreens (WBA) is facing a lawsuit over its alleged part in Kentucky's opioid crisis, which has the sixth-highest death rate from the drugs in the U.S.
OxyContin Maker Purdue Pharma Stops Promoting Opioids
Purdue Pharma, the maker of OxyContin, says that it will no longer be promoting the drug to doctors and is cutting its sales force.
Opioid Crisis: McKesson Corporation Stock Drops After 60 Minutes Report
McKesson (MCK) stock was down today following a '60 Minutes' report on the company and the current opioid crisis in the U.S.
Sales Growth Hurt McKesson (MCK) Rating
McKesson Corp (NYSE:MCK) is one of 81 companies within the Health Care Providers & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. MCK's market value is $31.7 billion which places it in the top decile in its industry group. The ranking for MCK by Portfolio Grader places it 48 among the 81 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 444 among the 782 companies in the sector, and number 2,708 in the nearly 5,000 company Portfolio Grader universe.
Stock of McKesson (MCK) Falls to Sell
With a $30.4 billion market value, McKesson Corp (NYSE:MCK) ranks in the top decile in its industry group, Health Care Providers & Services, and in the top 10% of its sector group, Health Care, in market value. From the vantage point of investment attractiveness, The current Portfolio Grader ranking for MCK puts it 56 among the 82 companies in this industry group, giving it a below-average spot; in the third quartile of the sector with a ranking of 526 among the 782 companies in the sector, and number 3,161 in the nearly 5,000 company Portfolio Grader universe.
Industry Group Rank Analytics Limit McKesson (MCK) Ratings Upgrade to Hold
The current recommendation of Hold for McKesson Corp (NYSE:MCK) is computed using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
Earnings Visibility Metrics Restrict McKesson (MCK) Ratings Upgrade to Hold
McKesson Corp (NYSE:MCK) is classified as a component of the 82 company Health Care Providers & Services GICS industry group, which is part of the 781 company GICS Health Care sector. MCK's market value is $29.6 billion which places it in the top decile in its industry group. The ranking for MCK by Portfolio Grader places it 48 among the 82 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 424 among the 781 companies in the sector, and number 2,720 in the nearly 5,000 company Portfolio Grader universe.
Deleterious Quant Score Drop McKesson (MCK) to Sell
McKesson Corp (NYSE:MCK) is classified as a constituent of the 82 company Health Care Providers & Services GICS industry group, which is a segment of the 782 company GICS Health Care sector. MCK's market value is $28.6 billion which places it in the top decile in its industry group. The ranking for MCK by Portfolio Grader places it 54 among the 82 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 504 among the 782 companies in the sector, and number 3,188 in the nearly 5,000 company Portfolio Grader universe.
Earnings Visibility Keep McKesson (MCK) a Sell
McKesson Corp (NYSE:MCK) is classified as a constituent of the 82 company Health Care Providers & Services GICS industry group, which is a segment of the 785 company GICS Health Care sector. The market value of MCK is $28.6 billion which falls in the top decile in its industry group. The ranking for MCK by Portfolio Grader places it 55 among the 82 companies in this industry group, giving it a below-average spot; in the third quartile of the sector with a ranking of 494 among the 785 companies in the sector, and number 3,171 in the nearly 5,000 company Portfolio Grader universe.
Industry Group Rank Metrics Keep McKesson (MCK) Upgrade to Hold
Currently, McKesson Corp (NYSE:MCK) has a Hold using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. MCK has been upgraded from a Sell to a Hold in the last week.
Shrinking Industry Group Rank Keeps McKesson (MCK) a Sell
Currently, McKesson Corp (NYSE:MCK) has a Sell using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MCK has had from Portfolio Grader for 7 months.
Shrinking Earnings Visibility Keeps McKesson (MCK) a Sell
Portfolio Grader currently ranks McKesson Corp (NYSE:MCK) a Sell. With unique fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. MCK has maintained this ranking for 7 months.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
